NCT03304639 2026-04-13Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell CarcinomaNational Cancer Institute (NCI)Phase 2 Active not recruiting9 enrolled 11 charts
NCT02267603 2023-07-05Pembrolizumab in Treating Patients With Advanced Merkel Cell CancerNational Cancer Institute (NCI)Phase 2 Completed50 enrolled 11 charts 2 FDA